Lonza | LONN - Ordinary Share Capital



Lonza reported CHF72M in Ordinary Share Capital for its fiscal semester ending in December of 2024.


Ordinary Share Capital Change Date
Akzo Nobel EUR 171.01M 86.01M Jun/2025
Alcon AG USD 20M 0 Mar/2025
Almirall EUR 214.79M 189.17M Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
BASF EUR 892.52M 249.48M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Beiersdorf EUR 220.21M 27.79M Jun/2025
Covestro EUR 188.74M 259.67K Jun/2025
Demant DKK 205.72M 161.72M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Geberit 32.94M 0 Mar/2025
Genmab DKK 10M 56M Mar/2025
Givaudan CHF 92M 0 Jun/2024
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GN Store Nord DKK 145.61M 458.39M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Johnson Matthey GBP 197M 10M Mar/2025
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Philips EUR 950.57M 762.57M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
Sika AG CHF 1.5M 0 Jun/2023
Smith & Nephew USD 875.96M 700.96M Jun/2025
Solvay EUR 104.46M 132.54M Jun/2025
UCB EUR 584M 0 Dec/2024